ProCE Banner Activity

Management of BTK Inhibitor Associated Adverse Events: Current Practice Trends Among Healthcare Providers and Concordance With Expert Recommendations


This poster, presented at ASH 2020, highlights findings from responses entered in the CCO interactive tool on managing AEs associated with BTK inhibitors. Analysis of clinical practice trends suggest that management of these AEs by HCPs often diverges from evidence-based expert recommendations.

Released: January 07, 2021

Expiration: January 06, 2022


Additional Information

Kristen Rosenthal, PhD
Associate Director, Scientific Services
Clinical Care Options
Telephone: 855.224.2241